The product does not meet quality requirements due to a negative test result for the “appearance” parameter – altered appearance of the capsule filling compared with the approved specification. Potential effects: possible non‑compliance of therapy with documentation and uncertainty regarding treatment quality.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product due to the identified quality non‑conformity; patients should consult their doctor or pharmacist about further treatment and check the name and batch of their medicine.
The distribution of all batches of the medicinal product Sunitinib Vipharm 12.5 mg has been suspended throughout the country; the decision was given immediate enforceability; the product was sent for ...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related